... against malignant brain tumors cells.
The Cedars-Sinai team led by Pedro R. ... recruited dendritic cells, which initiate the anti-tumor response. The biomarker identified in this study is a result ...
... is believed to be the first to show direct and continual proportionality between the strength of anti-tumor responses and clinical benefits in cancer patients. This also may be the first documentation ...
... if a chemotherapeutic agent is working by looking for shrinkage in the tumor using imaging techniques, such as MRI or PET, or pathological response at time of surgery" said Julie Ostrander, Duke ...
... undergone RFA.
"The additional survival benefit of RFA can be attributed to improved local tumor response of RFA, which in turn can be explained by the fact that more predictable tumor ablation was ...
... author. "In glioblastoma clinical trials, it is important to separate survival analysis from that of tumor response to therapy, since many factors combine to cause patient deaths."
Cediranib ...
... residing in the tumor," explained Juan R. Cubillos-Ruiz, graduate student and first author. ... locations, provoking anti-tumor responses and also directly killing tumor cells. The effect is particularly ...
... response modifier, which is a drug or a compound that changes the function of tumor cells so they will be more responsive to chemotherapy or radiation, according to Burd.
Key members of his research ...
... , the other Avastin given with CPT-11. An independent radiological facility was used to measure tumor responses, Cloughesy said.
In the Avastin only arm, 28.2 percent of patients responded to the ...
... T cells to hunt down and kill tumor cells.
"Inserted anywhere under the skin ... creating an especially potent anti-tumor response.
"This approach is able to simultaneously upregulate the destructive ...
... tongue. Study participants were given an initial course of chemotherapy to gauge the tumor’s response. Those whose tumor was reduced by more than half of its original size received a full course of ...
... deoxyribonucleic acid (DNA) to modulate the body’s anti-tumor response. Enabling a patient’s immune system ... 40 percent of patients developed immune responses to PSA, with anti-PSA antibodies produced ...
... tremelimumab to traditional treatment is not only safe, but an effective way to induce an anti-tumor response, which is very exciting.”
For this study, 16 patients diagnosed with stage 4 melanoma, ...
... cancer cells in the laboratory – with surprisingly good results. The scientists say the anti-tumor response primarily involves granulocytes of the innate immune system, a system known for fighting ...
... of tumor shrinkage as determined by an independent review. The researchers also analyzed the duration of tumor response, progression-free survival, and drug safety.
Stable Disease in 67 percent of ...
... completion of therapy. Researchers monitored the effects of this combined therapy by observing the side effects, tumor response, and overall survival.
Researchers found most tumors were of the " ...
